Healthcare 2035

Dealing in the new health landscape

Person in laboratory

Discover how technology, consumer behaviour and investment are reshaping global healthcare.

From AI‑supported drug discovery to virtual hospitals and smart sensors that help flag illness risk before symptoms, healthcare is changing fast.

Digital innovation, shifting consumer expectations and pressure on public health systems are creating a new landscape—one where many traditional models of care and delivery are coming under strain. In this context, dealmakers, investors and healthcare leaders have a clear opportunity: to shape the future of care by backing the platforms, partnerships and technologies that could define the next decade.

Healthcare 2035 explores the forces transforming the sector and highlights four sub‑sectors where value is likely to be created. It is a call to action for those ready to help move from fragmented systems to integrated, tech‑enabled ecosystems.

Download the full report

What’s changing now?

AI, robotics, wearables and data are changing how care is delivered, predicted and prevented.

  • AI drug discovery will help compress development timelines from decades to years.
  • Smart sensors enable remote monitoring and proactive care.
  • Robotic‑assisted surgery can improve outcomes and hospital efficiency These advances are not theoretical—they are already reshaping how people experience care.
  • Public systems under strain
    In the UK, health spending now accounts for 16p in every £1 of government expenditure. Chronic illness and economic inactivity are rising, while NHS leaders say targets are unachievable without capital investment.
  • Consumers take charge
    People are increasingly acting as healthcare consumers. 95% of the 500,000 UK users of GLP-1 weight loss drugs accessed them privately. Wellness spending is rising, and new health propositions are becoming non-negotiable.  
  • Pharma tech and services: AI is reshaping drug discovery, enabling personalised therapies and more decentralised trials
  • Digital health: Ambient scribing, virtual care and automation are streamlining delivery and expanding access
  • Biopharma: Precision medicine, gene therapies and new deal structures are pushing innovation
  • Consumer health: Private equity is funding growth in wellness platforms, over the counter (OTC) products and employer‑led care

Access the full insights

If you’re deploying capital in healthcare, timing and selection matter. Our full report maps emerging value pools and translates them into actionable deal opportunities. It connects demand shifts, technology adoption and policy change to clear investment theses you can act on.

Use it to sharpen origination, prioritise pipelines and pressure‑test assumptions. We highlight where to play, when to move and the execution levers that create value post‑close—so you can move first, with conviction.

Ready for what’s next in healthcare?

Discover the trends, technologies and M&A opportunities shaping the future of care.

(PDF of 1.03MB)

Contact us

Jaymal Patel

Jaymal Patel

Financial due diligence Partner, PwC United Kingdom

Tel: +44 (0)7841 566876

Stephen Aherne

Stephen Aherne

Strategy& Deals and Valuations Partner, PwC United Kingdom

Tel: +44 (0)7887 573735

Suzanne Ellis

Suzanne Ellis

Delivering Deal Value Partner, PwC United Kingdom

Tel: +44 (0)7717 801912

Follow us